Stocknear Logo Stocknear
/
Popular
Login

SAB Biotherapeutics Inc.

1.05
-0.13 (-11.02%)
At close: Apr 04, 2025, 3:06 PM

SAB Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Revenue peaked at - in undefined and hit its lowest at - in undefined. Over the past five years, it has declined by undefined%.

undefined

n/a
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
-34.11M -42.19M -17.14M -17.14M 20.12M -8.99M
4.79M 3.75M 1.65M 1.65M 548.18K 323.41K
2.94M 2.42M 2.67M 2.31M 1.3M 371.39K
n/a -528.64K 3.83M 3.83M 100K 84.5K
-7.92M 8.58M 3.48M 3.48M -2 1.00
n/a n/a n/a n/a -2.25K 421.00
n/a 2.33M 13.45M 13.45M -11.95M -923.37K
-34.29M -25.12M 3.76M 3.76M 10M -9.21M
n/a -197.15K -10.94M -10.94M -12.73M -608.75K
n/a n/a 76.39K n/a 9K n/a
-37.45M n/a n/a n/a n/a n/a
25.82M n/a n/a n/a n/a n/a
-337.26K 44.45K -76.39K -10.94M n/a n/a
-11.96M -152.7K -10.94M -10.94M -12.72M -608.75K
n/a -390.44K -1.19M 1.54M -917.88K n/a
n/a n/a -5.52M n/a n/a n/a
n/a n/a n/a n/a n/a n/a
-1.17M 59.66M 76.97K 32.58M n/a -4.3M
-1.17M 66.77M 34.12M 34.12M 8.98M 3.68M
-47.67M 41.52M 26.93M 26.93M 6.26M -6.14M
-34.29M -25.32M -7.19M -7.19M -2.73M -9.82M

Create Price Alert on SABS

Your price alert will notify you when the stock price is above 1.05.

Add to Watchlist